Purchases and Sales Made in Q4 2021 in Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX) during Q4 2021. The information is specifically focused on institutions that hold shares of Crinetics Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-2.9K- 13.49% |
$56.1K - $82.4K
|
18.6K
$711K
|
|
|
Feb 14, 2022
Q4 2021
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-4.15K- 25.15% |
$80.2K - $118K
|
12.3K
$471K
|
|
|
Feb 14, 2022
Q4 2021
|
Virtus ETF Advisers LLC
New York, NY |
SELL
|
- |
-4.5K- 40.08% |
$87.1K - $128K
|
6.73K
$257K
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-9K- 6.15% |
$174K - $256K
|
137K
$5.25M
|
|
|
Jun 21, 2023
Q4 2021
|
Met Life Investment Management, LLC
Whippany, NJ |
SELL
|
- |
-11.7K- 41.69% |
$226K - $332K
|
16.4K
$625K
|
|
|
Feb 07, 2022
Q4 2021
|
Sg Americas Securities, LLC
|
SELL
|
- |
-12.9K- 66.96% |
$250K - $367K
|
6.37K
$243K
|
|
|
Feb 14, 2022
Q4 2021
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-19.3K- 92.23% |
$374K - $549K
|
1.63K
$62.2K
|
|
|
Feb 14, 2022
Q4 2021
|
Blackstone Inc
New York, NY |
SELL
|
- |
-24.3KClosed |
$471K - $691K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-31K- 44.92% |
$599K - $880K
|
38K
$1.45M
|
|
|
Feb 16, 2022
Q4 2021
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-31.7K- 21.1% |
$613K - $899K
|
118K
$4.52M
|
|
|
Feb 11, 2022
Q4 2021
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-60.8K- 67.5% |
$1.18M - $1.73M
|
29.3K
$1.12M
|
|
|
Feb 07, 2022
Q4 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-80.7K- 41.28% |
$1.56M - $2.29M
|
115K
$4.39M
|
|
|
Jan 21, 2022
Q4 2021
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-82.3K- 98.99% |
$1.59M - $2.34M
|
843
$32.2K
|
|
|
Feb 14, 2022
Q4 2021
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-93.2K- 10.12% |
$1.8M - $2.65M
|
827K
$31.6M
|
|
|
Feb 14, 2022
Q4 2021
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-125K- 22.86% |
$2.43M - $3.56M
|
423K
$16.2M
|
|
|
Feb 11, 2022
Q4 2021
|
Versant Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-410K- 50.0% |
$7.94M - $11.7M
|
410K
$15.7M
|
|
|
Feb 03, 2022
Q4 2021
|
5 Am Venture Management, LLC
San Francisco, CA |
SELL
|
- |
-500K- 36.7% |
$9.68M - $14.2M
|
862K
$33M
|
|
|
Feb 11, 2022
Q4 2021
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-517KClosed |
$10M - $14.7M
|
0
$0
|